MX Orthopedics Receives FDA Clearance for dynaMX Compression Staple
MX Orthopedics received FDA 510(k) clearance to market the dynaMX™ Compression Staple, a superelastic Nitinol-based device. Feb 10, 2016
Five-Year Results of Mobi-C Cost Utility Analysis
Studies concluded that, for patients with 2-level degenerative disc disease, cervical total disc replacement appears to be highly cost-effective vs. ACDF, and supports greater quality of life at less cost. Feb 10, 2016
Tyber Medical Launches TyWedge Evans And Cotton Osteotomy Wedge Systems
Tyber Medical commenced full market launch of its TyWedge™ Osteotomy Wedge System, featuring TyPEEK® proprietary titanium plasma-sprayed PEEK coating specifically indicated for fusion. Feb 09, 2016
Ellipse Technologies Withdraws IPO
Ellipse Technologies withdrew its plans for a US $75MM initial public offering, filed in 4Q15, in light of its pending acquisition by NuVasive. Feb 09, 2016
Tentative Date for FDA Advisory Panel Review of Cartiva SCI
FDA tentatively scheduled a 2Q16 meeting of the Orthopaedic and Rehabilitation Devices Panel to review Cartiva’s Premarket Approval Application for the Synthetic Cartilage Implant in the treatment of great toe osteoarthritis. Feb 09, 2016
OrthAlign’s Multi-country Distribution Agreement with Smith & Nephew
OrthAlign entered into a multi-country distribution agreement with Smith & Nephew for its KneeAlign® Total Knee Arthroplasty component alignment technology. Feb 09, 2016
First Implantation of VGI Medical’s VerteLP Lateral Lumbar Cage with Bi-Cortical Fixation
VGI Medical announced successful implantation of the first VerteLP® Lateral Lumbar Cage. Feb 08, 2016
CollPlant Reports Final Trial Results for VergenixSTR in the Treatment of Tendinopathy
CollPlant announced positive final clinical trial results for Vergenix™STR, intended for the treatment of tendinopathy. Feb 04, 2016
Medovex Receives Reimbursement for DenerveX Facet Joint Syndrome Treatment in Germany
The German reimbursement authority released new reimbursement payment coding for the Medovex DenerveX™ system for the treatment of facet joint syndrome. Feb 04, 2016
Histogenics Completes 50% Enrollment in NeoCart Phase III Trial
Histogenics has completed >50% of the required enrollment in its ongoing NeoCart® Phase III clinical trial in the treatment of knee cartilage defects. Feb 03, 2016
